Midgard

Franklin Biolabs

King of Prussia, PA, United States franklinbio.com From their website, Nov 2026

  • GLP
  • GMP

Work here? Claim this listing

About

Franklin Biolabs is a preclinical CRO based in Philadelphia that supports genetic medicines and biologics development. It works with biotech, pharma, and academic groups on vector production, analytical testing, preclinical and translational studies, pathology, immunology, and bioanalysis.

Services

  • Research Vector Production

    Produces research-grade AAV, adenovirus, and lentivirus vectors for preclinical in vitro and in vivo studies.

    Protein production

  • Large-Scale AAV Manufacturing

    Provides scaled AAV vector manufacturing to support preclinical investigations and clinical trial readiness.

    Protein production

  • Process Development

    Develops product-specific manufacturing processes using adherent and suspension culture platforms and novel analytics.

    Protein production

  • Analytical Testing

    Characterizes drug substance and drug product with analytical assays for preclinical through clinical stages.

  • Chemistry, Manufacturing, & Controls (CMC) Consulting

    Provides end-to-end CMC support connecting manufacturing, analytics, and preclinical development for advanced therapies.

  • Preclinical Translational Pharmacology & Toxicology

    Runs non-GLP and GLP dose-ranging, pharmacology, and toxicology studies for advanced therapeutics.

    ADME, DMPK & toxicology

  • Pharmacokinetics

    Supports pharmacokinetic studies as part of its preclinical and translational program.

    ADME, DMPK & toxicology

  • Histology & Histopathology

    Provides necropsy, tissue collection, histology, pathology, staining, imaging, and interpretation services.

5 more services
  • Bioanalytics
  • Immunogenicity
  • Biodistribution
  • Viral Shedding
  • Biomarkers
Turnaround
3 weeks to 24 months
What to send
  • Country/Region
  • Services Involved
  • Regulatory Status

Capabilities

Assays and studies
  • AAV
  • Immunogenicity
  • Bioanalysis
  • Toxicology
  • In vivo
  • Histopathology
15 more
  • Process development
  • PK/PD
  • Lentivirus
  • Analytical testing
  • Integrated molecular and immunogenicity bioanalysis
  • Biodistribution
  • Viral shedding
  • Biomarkers
  • Histology
  • Immunohistochemistry
  • Immunofluorescence
  • Multiplex in situ hybridization
  • Whole slide imaging
  • Pharmacology
  • Efficacy
Scale and capacity
  • 150,000 sq. ft. of manufacturing, analytics, and in vivo study areas
  • Over 75,000 sq. ft. of animal facility space
  • Over 50 GMP manufacturing runs
Therapeutic areas
  • Gene therapy
  • Cell therapy
  • Genetic medicines
  • Biologics
  • CNS
  • Ocular

Instruments and platforms

  • Advanced Cell Diagnostics (ACD) ISH platforms

Modalities and species

Modalities
  • Viral vector
  • Cell therapy
  • Vaccine
Species and models
  • Mice
  • Rats
  • Rabbits
  • Nonhuman primates
  • Rodent models
  • Customized animal models

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GLPSelf-reported

  • AAALACSelf-reported

    As listed: AAALAC International

  • GMPSelf-reported

Company

Type
CRO
Founded
2019
Ownership
Small business, as registered with SAM.gov or stated on their site

Locations

Based in
King of Prussia, PA, United States
Sites
Philadelphia, United States
Serves
Global, worldwide, 30+ countries

Public records

FDA drug establishment registration
3035146402 · ANALYSIS source
CMS CLIA laboratory
39D2329722 · KING OF PRUSSIA source

Similar labs